Kochupurackal Parameswarannayar Mohanakumar

Kochupurackal Parameswarannayar Mohanakumar

Auto-generated profile, based on publicly available information

Kochupurackal Parameswarannayar Mohanakumar

Indian Institute of Chemical Biology

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2013 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
JCJoy Chakraborty
Joy Chakraborty
RSRaghavendra Singh
Raghavendra Singh
DDDebashis Dutta
Debashis Dutta
ANAmit Naskar
Amit Naskar
URUsha Rajamma
Usha Rajamma
KMKochupurackal P. Mohanakumar
Kochupurackal P. Mohanakumar

14 December 2006 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
KSKaruppagounder S. Saravanan
Karuppagounder S. Saravanan
KSKizhakke M. Sindhu
Kizhakke M. Sindhu
KMKochupurackal P. Mohanakumar
Kochupurackal P. Mohanakumar

29 December 2008 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
MBM Kathleen Borland
M Kathleen Borland
PTPatricia A Trimmer
Patricia A Trimmer
JRJeremy D Rubinstein
Jeremy D Rubinstein
PKPaula M Keeney
Paula M Keeney
KMKp Mohanakumar
Kp Mohanakumar
JBJames P Bennett
James P Bennett
Background: Parkinson's disease, the most common adult neurodegenerative movement disorder, demonstrates a brain-wide pathology that begins pre-clinically with alpha-synuclein aggregates ("Lewy neurites") in processes of gut enteric and vagal motor neurons. Rostral progression into substantia nigra with death of dopamine neurons produces the motor impairment phenotype that yields a clinical diagnosis. The vast majority of Parkinson's disease occurs sporadically, and current models of sporadic Parkinson's disease (sPD) can utilize directly infused or systemic neurotoxins. Results: We developed a differentiation protocol for human SH-SY5Y neuroblastoma that yielded non-dividing dopaminergic neural cells with long processes that we then exposed to 50 nM rotenone, a complex I inhibitor used in Parkinson's disease models. After 21 days of rotenone, ~60% of cells died. Their processes retracted and accumulated ASYN-(+) and UB-(+) aggregates that blocked organelle transport. Mitochondrial movement velocities were reduced by 8 days of rotenone and continued to decline over time. No cytoplasmic inclusions resembling Lewy bodies were observed. Gene microarray analyses showed that the majority of genes were under-expressed. qPCR analyses of 11 mtDNA-encoded and 10 nDNA-encoded mitochondrial electron transport chain RNAs' relative expressions revealed small increases in mtDNA-encoded genes and lesser regulation of nDNA-encoded ETC genes. Conclusion: Subacute rotenone treatment of differentiated SH-SY5Y neuroblastoma cells causes process retraction and partial death over several weeks, slowed mitochondrial movement in processes and appears to reproduce the Lewy neuritic changes of early Parkinson's disease pathology but does not cause Lewy body inclusions. The overall pattern of transcriptional regulation is gene under-expression with minimal regulation of ETC genes in spite of rotenone's being a complex I toxin. This rotenone-SH-SY5Y model in a differentiated human neural cell mimics changes of early Parkinson's disease and may be useful for screening therapeutics for neuroprotection in that disease stage.

11 December 2003 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
BTBobby Thomas
Bobby Thomas
KMKochupurackal P. Mohanakumar
Kochupurackal P. Mohanakumar

23 February 2015 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
ANAmit Naskar
Amit Naskar
VPVisakh Prabhakar
Visakh Prabhakar
RSRaghavendra Singh
Raghavendra Singh
DDDebashis Dutta
Debashis Dutta
KMKochupurackal P. Mohanakumar
Kochupurackal P. Mohanakumar

1 May 2002 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KMKochupurackal P. Mohanakumar
Kochupurackal P. Mohanakumar
BTBobby Thomas
Bobby Thomas
SSSudarshana M. Sharma
Sudarshana M. Sharma
DMDhanasekharan Muralikrishnan
Dhanasekharan Muralikrishnan
RCRukhsana Chowdhury
Rukhsana Chowdhury
CCChuang C. Chiueh
Chuang C. Chiueh